Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of bronchodilator- and budesonide-based treatment protocols for cough variant asthma
ChiCTR-TRC-09000370Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diprophylline, terbutaline, budesonide and formoterol in cough variant asthma (CVA) (3 arms), sponsored by Tongji Hospital. Primary endpoints: Cough symptom score, Cough sensitivity test and 1 more. Started Apr 2009; status: completed.
02
Drugs
diprophyllineterbutalinebudesonideformoterol
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR-TRC-09000370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000370.